Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-19

Clinical Trial Update: Argatroban Stroke Treatment - A Pilot Safety Study [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/2 pilot safety study of argatroban for ischemic stroke, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Angiomax (bivalirudin)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Ischemic Stroke | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-09-19